Jal Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.21 M
as on 16-11-2024
- Company Age 51 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.21 Cr
as on 16-11-2024
- Satisfied Charges ₹ 2.07 M
as on 16-11-2024
- Revenue %
(FY 2023)
- Profit -97.35%
(FY 2023)
- Ebitda 96.00%
(FY 2023)
- Net Worth 0.14%
(FY 2023)
- Total Assets 4.83%
(FY 2023)
About Jal
The Corporate was formerly known as Jal Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.21 M.
The company currently has active open charges totaling ₹1.21 Cr. The company has closed loans amounting to ₹2.07 M, as per Ministry of Corporate Affairs (MCA) records.
Jayesh Choksi, Pranav Choksi, Vipula Choksi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ1973PTC002258
- Company No.
002258
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 1973
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Navsari, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Jal?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayesh Choksi  | Director | 12-Apr-1973 | Current |
| Pranav Choksi | Director | 01-Oct-2004 | Current |
| Vipula Choksi | Director | 01-Mar-1998 | Current |
| Pankaj Gandhi | Director | 28-Mar-2017 | Current |
Financial Performance of Jal.
Jal Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 97.35% decrease in profit. The company's net worth moved up by a moderate rise of 0.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jal?
In 2023, Jal had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gufic Biosciences LimitedActive 40 years 5 monthsJayesh Choksi, Pranav Choksi and 1 more are mutual person
- Gufic Private LimitedActive 53 years 8 months
Jayesh Choksi, Pranav Choksi and 2 more are mutual person
- Gufic Chem Private LimitedActive 41 years 3 months
Jayesh Choksi, Pranav Choksi and 2 more are mutual person
- Zircon Teconica Private LimitedActive 38 years 10 months
Jayesh Choksi, Pranav Choksi and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dena Bank Creation Date: 11 Jun 1996 | ₹1.01 Cr | Open |
Indian Bank Creation Date: 11 Sep 1990 | ₹2.00 M | Open |
Dena Bank Creation Date: 04 Sep 1984 | ₹1.20 M | Satisfied |
How Many Employees Work at Jal?
Unlock and access historical data on people associated with Jal, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jal, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jal's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
